Publications

February 1992 (Revised April 1995)
Case

Pfizer: Global Protection of Intellectual Property

By: Lynn S. Paine and Michael Santoro

Top officials at Pfizer are assessing their strategy for improving protection of Pfizer's patents around the world. The outcome of the Uruguay Round of the GATT negotiations is uncertain, and it is not clear whether an acceptable intellectual property protection... View Details

Keywords: Patents; Trade; Policy; Government and Politics; Business Strategy; Agreements and Arrangements; Alliances; Cross-Cultural and Cross-Border Issues; Pharmaceutical Industry; United States; Japan; Europe

January 1992
Teaching Note

Advanced Medical Technology Corporation TN

By: Thomas R. Piper

Teaching Note for (9-287-028). View Details

Keywords: Pharmaceutical Industry

November 1991 (Revised December 1991)
Case

SmithKline Beecham Animal Health

By: Ray A. Goldberg

Keywords: Pharmaceutical Industry; Pharmaceutical Industry

September 1991 (Revised August 1994)
Background Note

Note on Pharmaceutical Industry Regulation

By: Willis M. Emmons III

Traces the evolution of U.S. regulatory policy towards the pharmaceutical industry over the course of the twentieth century. A major theme is the steady shift away from a policy of 'let the buyer beware' to the creation of a complex and time-consuming review process,... View Details

Keywords: Safety; Industry Growth; Marketing; Research and Development; Health Testing and Trials; Economics; Pharmaceutical Industry; United States

September 1991 (Revised February 1993)
Case

Burroughs Wellcome and AZT (A)

By: Willis M. Emmons III

Burroughs Wellcome Co., developer of AZT, the first drug approved by the U.S. Food and Drug Administration for the treatment of Acquired Immune Deficiency Syndrome (AIDS), finds itself under siege in September 1989 by AIDS activists and various segments of the U.S.... View Details

Keywords: Governing Rules, Regulations, and Reforms; Ethics; Business and Government Relations; Communication Strategy; Health Care and Treatment; Monopoly; Intellectual Property; Research and Development; Price; Pharmaceutical Industry; London

Article

Pharmaceutical Marketing Practices in the Third World

By: N. Craig Smith and John A. Quelch

June 1991
Case

Eli Lilly and Co.: European Pharmaceutical Operations

Keywords: Multinational Firms and Management; Pharmaceutical Industry; Europe

October 1990 (Revised April 1991)
Case

RU 486 (A)

By: Joseph L. Badaracco Jr.

Describes the factors faced by Roussel UCLAF, a French drug company, in deciding whether and how to market a controversial new drug, RU 486, which is often called "the French abortion pill." Roussel's decision involved its relations with the French government, its... View Details

Keywords: Judgments; Ethics; Product Launch; Negotiation; Outcome or Result; Performance; Business and Government Relations; Pharmaceutical Industry; Pharmaceutical Industry; France; Germany; United States

September 1990 (Revised March 1991)
Supplement

RU 486 (B)

By: Joseph L. Badaracco Jr.

Describes how Roussel UCLAF resolved the dilemma. Intended for use as an in-class handout. View Details

Keywords: Pharmaceutical Industry; Pharmaceutical Industry; France; Germany; United States

September 1990 (Revised January 1992)
Case

Eli Lilly and Co. (A): Globalization

Examines the changes taking place in Eli Lilly in response to the globalization of the pharmaceuticals industry. Identifies the steps taken by management, problems currently faced, and challenges for the future. Allows examination of the process of implementing a... View Details

Keywords: Change; Globalization; Global Strategy; Business or Company Management; Problems and Challenges; Perspective; Pharmaceutical Industry

August 1990 (Revised January 1992)
Case

Eli Lilly and Co. (B): Europe

Examines the challenges facing the company in light of the changing economic, regulatory, and competitive environment in the European pharmaceutical industry. Examines the steps taken by the company adapting to this changing situation as part of a total globalization... View Details

Keywords: Change Management; Economics; Global Strategy; Business or Company Management; Growth and Development Strategy; Adaptation; Competition; Pharmaceutical Industry; Europe

August 1990 (Revised March 1991)
Case

Eli Lilly and Co. (C): Japan

Describes the process of establishing an independent operation in Japan in the mid-1980s as a result of a decision to make a major investment in the market. Describes the challenges in setting up such an operation and focuses on the role of the country manager in... View Details

Keywords: Business Divisions; Business Startups; Decisions; Investment; Growth Management; Managerial Roles; Markets; Problems and Challenges; Pharmaceutical Industry; Japan

June 1990
Teaching Note

International Pharmaceuticals Inc. (Abridged), Teaching Note

By: James E. Austin and Tomas Otto Kohn

Keywords: Pharmaceutical Industry